Biotech News
ImmunityBio Named No. 2 Fastest-Growing Technology Company in North America on the 2026 Deloitte Technology Fast 500™
Ranking reflects significant revenue growth over last three years and continued global expansion of ANKTIVA ®, now authorized in 35 countries CULVER CITY, Calif. --(BUSINESS WIRE)--Nov. 19, 2026-- ImmunityBio, Inc. ( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that it
